Skip to content
OpenCapital
Get started

DexCom DXCM Market capitalization

Other financials

Income statement

See full
Revenue$1.2B+15.0%
Gross profit$750.3M+27.4%
Operating income$255.3M+91.0%
Net income$199.5M+89.3%
EPS (diluted)$0.51+88.9%

Balance sheet

See full
Cash & equivalents$1.1B+23.4%
Total debt$143.0M+2.2%
Total equity$3.0B+30.5%
Total assets$6.6B-1.8%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation

See full
Enterprise value$26.51B-10.8%
P/E29.5×-27.4×
P/S5.7×-1.6×

Profitability

See full
Gross margin61.5%+2.1pp
Operating margin21.4%+6.2pp
Net margin19.3%+6.4pp

Returns & leverage

See full
Return on equity35.6%+11.9pp
Debt / equity0×0.0×
Current ratio1.9×+0.4×

Where this comes from

Computed from the period-end share price: $24.17B.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's market capitalization.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DexCom's market capitalization?
DexCom (DXCM) reported market capitalization of $24.17B in Q1 2026.
How has DexCom's market capitalization changed year-over-year?
DexCom's market capitalization decreased by 9.7% year-over-year, from $26.78B to $24.17B.
What is the long-term trend for DexCom's market capitalization?
Over 4 years (2021 to 2025), DexCom's market capitalization has grown at a -11.1% compound annual growth rate (CAGR), from $181.26B to $113.39B.
What does market capitalization mean?
What the stock market says the company's equity is worth.
How do you interpret market capitalization?
A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
How does market capitalization compare across companies?
Comparable across companies as a size class; the input to every equity-price valuation multiple.